IL6 and Hutchinson-Gilford progeria syndrome: Celastrol and AZD1981, identified in our previous drug and investigational agent library qHTS, inhibit cellular senescence and IL-6 secretion in fibroblasts derived from HGPS patients, recapitulating the beneficial effects exerted by lentiviral expression of Δ133p53α.